As per the latest report, Global Muscle Hypertonia Treatment Market, by Drug Type (Baclofen, Diazepam, Dantrolene), By Prognosis (Mild Condition, Moderate Condition, Severe Condition) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) by Meridian Market Consultants, the growing incidence of muscle hypertonia and improving treatment-seeking rates are the factors attributed to growth in global muscle hypertonia treatment market. MMC predicts that the market will grow at a significant CAGR for the period between 2019 and 2027.
As per the report, the growing incidence of muscle hypertonia and improving treatment-seeking rates are the factors attributed to growth in global muscle hypertonia treatment market. Hypertonia is used synonymously with muscle spasticity and muscle rigidity. Muscle hypertonia is a common finding in patients with upper motor neuron syndrome. Muscle hypertonia is characterized by increased muscle tone which causes stiffness in hands and legs. Causes of muscle hypertonia can be blow to the head, stroke, brain tumors, neurodegenerative diseases, cerebral palsy, multiple sclerosis, Parkinson’s disease, etc. Muscle hypertonia limits the movement of joints hence limits the body functions such as walking, balancing etc. If hypertonia is severe, it can cause a joint to become frozen, which is called as a joint contracture. The prognosis of muscle hypertonia depends on severity of the disease and underlying cause. For instance, in case of cerebral palsy muscle hypertonia can last lifelong. In other conditions hypertonia may worsen along with the underlying disease. If hypertonia is mild it has little or no effect on person’s health. Moderate hypertonia may affect joint contracture. Severe muscle hypertonia causes immobility, risk of bone fracture, infection, bed sores, pneumonia etc.
Request free sample and PDF Brochure related to our latest study on Global Muscle Hypertonia Treatment Market @ Meridian Market Consultants
Furthermore, Meridian Market Consultants (MMC) Study identifies that, increasing awareness about muscle hypertonia is leading to increasing treatment seeking rates in countries such as U.S. Treatment of muscle hypertonia includes physical therapy and pharmacological therapy. Aim of physical therapy is to inhibit excessive muscle tone. Physiotherapy can control the muscle hypertonia through the use of stretching. Local anesthetics can decrease reflective activity. Shcok wave therapy is being used to treat muscle hypertonia since 1997. Pharmacological therapy involves treatment with muscle relaxing drugs such as baclofen, diazepam, and dantrolene. Baclofen is generally the drug of choice for spinal cord types of spasticity, while sodium dantrolene is the only agent which acts directly on muscle tissue. All of these drugs can be taken by mouth, but baclofen may also be injected directly into the cerebrospinal fluid through an implanted pump. Botulinum toxin is often used to relieve hypertonia in a specific area of the body.
MMC Study identifies some of the key participating players in Muscle Hypertonia Treatment market globally are Apotex Corporation, Sanis Health Inc., Sterimax Inc., Piramal Critical Care Inc., Mallinckrodt Inc., Novartis AG, Valeant Pharmaceuticals, Pfizer Inc., Procter & Gamble Pharmaceuticals, Par Pharmaceutical, Cardinal Health etc.
